{
  "id": 5579099,
  "title": "US-China biotech NeuShen gets $80M to develop brain-health drugs",
  "url": "https://urgent.news/2026/09/04/us-china-biotech-neushen-gets-80m-to-develop-brain-health-drugs",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-04T14:47:16.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/us-china-biotech-neushen-gets-80m-to-develop-brain-health-drugs/"
  },
  "original_language": "en",
  "account": null,
  "summary": "A Shanghai and Boston biotech led by a veteran transpacific drug developer has secured more than $80 million to advance three clinical-stage brain-health drugs. NeuShen Therapeutics disclosed the Series B this ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}